Epidemiology Analyst IVOptumMaynard, Massachusetts, United States
Disclosure information not submitted.
5C-06 - Incidence Rates of Myocarditis/Pericarditis after Pfizer-BioNTech COVID-19 Vaccine in the United States: Interim Results From a Postapproval Safety Study, Primary Series Analysis
Tuesday, August 26, 20259:45 AM - 10:00 AM ET